Uticaj pomoćnika za kontrolu glikemije uz pomoć MMC-a na biohemijske pokazatelje metabolizma glukoze kod dijabetesa tipa 2: retrospektivna studija

MMC-Based Intervention Improves Glucose Metabolism Biomarkers

  • Peipei Shen Odeljenje za endokrine i metaboličke bolesti, Narodna bolnica Pizhou
  • Hongjiao Yang Odeljenje za endokrine i metaboličke bolesti, Narodna bolnica Pizhou
DOI: https://doi.org/10.5937/jomb0-60285

Sažetak


Background: Accurate biochemical monitoring is central to effective diabetes management. This study investigated the effect of the National Standardized Metabolic Management Center (MMC)-assisted glycemic control assistant on laboratory-based glucose metabolism parameters in patients with type 2 diabetes.

Methods: A retrospective study was conducted on 160 patients with type 2 diabetes, including 95 who received MMC-assisted digital management and 65 who received routine care. Key biochemical parameters—fasting plasma glucose (FPG), 2-hour postprandial glucose (2hPG), and glycated hemoglobin (HbA1c)—were measured using standardized enzymatic assays. Dietary behavior and diabetes self-management were also assessed using validated scales.

Results: Baseline biochemical markers and behavioral scores showed no significant differences between groups. After intervention, the MMC-assisted group demonstrated significantly lower levels of FPG (7.42±2.43 vs. 8.30±2.66 mmol/L, P=0.032), 2hPG (10.23±3.21 vs. 12.39±3.50 mmol/L, P<0.001), and HbA1c (7.26±2.05% vs. 7.98±2.34%, P=0.041) compared to controls. Improvements were also observed in dietary behavior and self-management, including better adherence to blood glucose monitoring and medication.

Conclusion: The MMC-assisted glycemic control assistant significantly improves biochemical markers of glucose metabolism in patients with type 2 diabetes. This laboratory-confirmed improvement supports the integration of digital tools into standardized metabolic disease management.

Reference

1. Gong S, Gan S, Zhang Y, Zhou H, Zhou Q. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus. Front Endocrinol 2023; 14: 1248614.
2. Fina LJ, Omole OB, Francis JM. Protocol: Developing a framework to improve glycaemic control among patients with type 2 diabetes mellitus in Kinshasa, Democratic Republic of the Congo. Plos One 2022; 17(9): e0268177.
3. Du LJ, He ZY, Gu X, Hu X, Zhang XX, Yang LJ, et al. Inverse Association of Fruit and Vegetable Consumption with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus. Nutrients 2022; 14(21): 4559.
4. Ke J, Li K, Ke T, Zhong X, Zheng Q, Wang Y, et al. Association of sedentary time and carotid atherosclerotic plaques in patients with type 2 diabetes. J Diabetes 2022; 14(1): 64-72.
5. Han CY, Zhang J, Ye XM, Lu JP, Jin HY, Xu WW, et al. Telemedicine-assisted structured self-monitoring of blood glucose in management of T2DM results of a randomized clinical trial. Bmc Med Inform Decis 2023; 23(1): 182.
6. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43(Suppl 1): S14-31.
7. Tang H, Qin H, Zhang M, Zhang J, Tan H, Chen M, et al. Efficacy of a smartphone application for helping individuals with type 2 diabetes mellitus manage their blood glucose: a protocol for factorial design trial. Trials 2023; 24(1): 468.
8. Xu K, Zheng Q, Shao J, Yang L, Dai Y, Zhang J, et al. Sex differences in the association between visceral adipose tissue and atherosclerosis in type 2 diabetes patients with normal bodyweight: A study in a Chinese population. J Diabetes Invest 2023; 14(1): 92-101.
9. Wong I. Study of type 2 diabetes management among patients in a Macau primary care setting. Fam Med Community He 2019; 7(3): e000031.
10. Xu M, Chattopadhyay K, Qian X, Li J, Li X, Sun J, et al. Association Between Nocturnal Sleep Duration and Obesity Indicators Among People with Type 2 Diabetes: A Cross-Sectional Study in Ningbo, China. Diabet Metab Synd Ob 2022; 15: 1357-64.
11. Ossai CI, Wickramasinghe N. Automatic user sentiments extraction from diabetes mobile apps - An evaluation of reviews with machine learning. Inform Health Soc Ca 2023; 48(3): 211-30.
12. Gosak L, Pajnkihar M, Stiglic G. The Impact of Mobile Health Use on the Self-care of Patients With Type 2 Diabetes: Protocol for a Randomized Controlled Trial. Jmir Res Protoc 2022; 11(6): e31652.
13. Jadczyk T, Wojakowski W, Tendera M, Henry TD, Egnaczyk G, Shreenivas S. Artificial Intelligence Can Improve Patient Management at the Time of a Pandemic: The Role of Voice Technology. J Med Internet Res 2021; 23(5): e22959.
14. Zainuddin, Abdullah AZ, Jafar N, Suriah, Nursalam, Darmawansyah, et al. The application of social cognitive theory (SCT) to the mHealth diabetes physical activity (PA) app to control blood sugar levels of type 2 diabetes mellitus (T2DM) patients in Takalar regency. J Public Health Res 2023; 12(2): 1204273815.
15. Bults M, van Leersum CM, Olthuis T, Bekhuis R, den Ouden M. Barriers and Drivers Regarding the Use of Mobile Health Apps Among Patients With Type 2 Diabetes Mellitus in the Netherlands: Explanatory Sequential Design Study. JMIR Diabetes 2022; 7(1): e31451.
16. Carrier MA, Beverly EA. Focus on the Positive: A Qualitative Study of Positive Experiences Living With Type 1 or Type 2 Diabetes. Clin Diabetes 2021; 39(2): 176-87.
17. Kusnanto K, Pradipta RO, Arifin H, Gusmaniarti G, Handiyani H, Klankhajhon S. What I felt as a diabetes fatigue survivor: a phenomenology study. J Diabetes Metab Dis 2022; 21(2): 1753-62.
18. Hemphill RC, Stephens MA, Rook KS, Franks MM, Salem JK. Older adults' beliefs about the timeline of type 2 diabetes and adherence to dietary regimens. Psychol Health 2013; 28(2): 139-53.
19. Schwab S, Xu T, Ryan K, Steinle N. Eating behavior disinhibition predicts insulin resistance in the Old Order Amish. J Hum Nutr Food Sci 2017; 5(2): 1109.
20. Thomas A, Ashcraft AS, Owen DC, Conway-Phillips R. Making It All Work: Qualitative Descriptions of Hispanic Adults Managing Type 2 Diabetes With Limited Resources. Glob Qualit Nurs Res 2017; 4: 1984682796.
21. Chen HM, Su BY. Factors Related to the Continuity of Care and Self-Management of Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Taiwan. Healthcare-Basel 2022; 10(10): 2088.
22. Alshahri BK, Bamashmoos M, Alnaimi MI, Alsayil S, Basaqer S, Al-Hariri MT, et al. Assessment of Self-Management Care and Glycated Hemoglobin Levels Among Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study From the Kingdom of Saudi Arabia. Cureus J Med Science 2020; 12(12): e11925.
23. Castensoe-Seidenfaden P, Husted GR, Jensen AK, Hommel E, Olsen B, Pedersen-Bjergaard U, et al. Testing a Smartphone App (Young with Diabetes) to Improve Self-Management of Diabetes Over 12 Months: Randomized Controlled Trial. Jmir Mhealth Uhealth 2018; 6(6): e141.
24. Kebede MM, Schuett C, Pischke CR. The Role of Continuous Glucose Monitoring, Diabetes Smartphone Applications, and Self-Care Behavior in Glycemic Control: Results of a Multi-National Online Survey. J Clin Med 2019; 8(1): 109.
25. Kebede MM, Pischke CR. Popular Diabetes Apps and the Impact of Diabetes App Use on Self-Care Behaviour: A Survey Among the Digital Community of Persons With Diabetes on Social Media. Front Endocrinol 2019; 10: 135.
26. Guan C, Fu S, Zhen D, Yang K, An J, Wang Y, et al. Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center. J Diabetes Res 2022; 2022: 8429847.
27. Hu Y, Zheng J, Ye X, Song Y, Wu X. Association Between Elevated Thyroid Peroxidase Antibody and Abdominal Fat Distribution in Patients with Type 2 Diabetes Mellitus. Diabet Metab Synd Ob 2022; 15: 863-71.
Objavljeno
2025/09/04
Broj časopisa
Ahead of print
Rubrika
Original paper

Sva prava zadržana (c) 2025 Peipei Shen, Hongjiao Yang

Creative Commons License

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.